Toll-Like Receptor 4 Promotes α-Synuclein Clearance and Survival of Nigral Dopaminergic Neurons

Stefanova, Nadia, Fellner, Lisa, Reindl, Markus, Masliah, Eliezer, Poewe, Werner, Wenning, Gregor K.·2011·The American Journal of Pathology
DOI 10.1016/j.ajpath.2011.04.013

Cited by (272)

Items 101–200 of 272

  1. Microglia as therapeutic target in central nervous system disorders
    Oluwaseun Fatoba, Takahide Itokazu, Toshihide Yamashita · 2020 · Journal of Pharmacological Sciences
  2. Oligodendroglial alpha-synucleinopathy and MSA-like cardiovascular autonomic failure: Experimental evidence
    Daniela Kuzdas-Wood, Sylvia Stemberger, Stefano Gaburro, Nadia Stefanova, Nicolas Singewald, Gregor Karl Wenning · 2013 · Experimental Neurology
  3. Review: Multiple system atrophy: emerging targets for interventional therapies
    Nadia Stefanova, Gregor Karl Wenning · 2016 · Neuropathology and Applied Neurobiology
  4. Inflammatory pre-conditioning restricts the seeded induction of α-synuclein pathology in wild type mice
    Emily J. Koller, Mieu Brooks, Todd Eliot Golde, Benoit I. Giasson, Paramita Chakrabarty · 2017 · Molecular Neurodegeneration
  5. Telomere shortening leads to an acceleration of synucleinopathy and impaired microglia response in a genetic mouse model
    Scheffold, Annika, Holtman, Inge R., Dieni, Sandra, Brouwer, Nieske, Katz, Sarah-Fee, Jebaraj, Billy Michael Chelliah, Kahle, Philipp J., Hengerer, Bastian, Lechel, André, Stilgenbauer, Stephan et al. · 2016 · Acta Neuropathologica Communications
  6. Activated microglia facilitate the transmission of α-synuclein in Parkinson's disease
    Tingting Zheng, Zhengxiang Zhang · 2021 · Neurochemistry International
  7. Proteostasis of α-Synuclein and Its Role in the Pathogenesis of Parkinson’s Disease
    Deqiang Han, Wei Zheng, Xueyao Wang, Zhiguo Chen · 2020 · Frontiers in Cellular Neuroscience
  8. The role of glia in protein aggregation
    Qingyun Li, Michael Seamus Haney · 2020 · Neurobiology of Disease
  9. Neurons and Glia Interplay in α-Synucleinopathies
    Panagiota Mavroeidi, Maria Xilouri · 2021 · International Journal of Molecular Sciences
  10. Association of Glial Activation and α-Synuclein Pathology in Parkinson’s Disease
    Rui Wang, Haigang Ren, Elena V. Kaznacheyeva, Xiaojun Lu, Guanghui Wang · 2022 · Neuroscience Bulletin
  11. Regulation of α-synuclein homeostasis and inflammasome activation by microglial autophagy
    Insup Choi, George R. Heaton, You-Kyung Lee, Zhenyu Yue · 2022 · Science Advances
  12. TLR-Mediated Signal Transduction and Neurodegenerative Disorders
    Adhikarla, Shashank Vishwanath, Jha, Niraj Kumar, Goswami, Vineet Kumar, Sharma, Ankur, Bhardwaj, Anuradha, Dey, Abhijit, Villa, Chiara, Kumar, Yatender, Jha, Saurabh Kumar · 2021 · Brain Sciences
  13. Alpha-synuclein activates the classical complement pathway and mediates complement-dependent cell toxicity
    Emil Gregersen, Cristine Betzer, Woojin Scott Kim, Gergő E. Kovács, Lasse Reimer, Glenda Margaret Halliday, Steffen Thiel, Poul Henning Jensen · 2021 · Journal of Neuroinflammation
  14. Neuroinflammation in Parkinson's Disease and Related Disorders: A Lesson from Genetically Manipulated Mouse Models of α -Synucleinopathies
    Kazunari Sekiyama, Shuei Sugama, Masayo Fujita, Akio Sekigawa, Yoshiki Takamatsu, Masaaki Waragai, Takato Takenouchi, Makoto Hashimoto · 2012 · Parkinson s Disease
  15. Unravelling the role of gut microbiota in Parkinson’s disease progression: Pathogenic and therapeutic implications
    Linchi Rani, Amal Chandra Mondal · 2021 · Neuroscience Research
  16. Failure of Neuroprotection Despite Microglial Suppression by Delayed-Start Myeloperoxidase Inhibition in a Model of Advanced Multiple System Atrophy: Clinical Implications
    Christine Kaindlstorfer, Patrick Sommer, Biljana Georgievska, Robert J. Mather, Alan R. Kugler, Werner H Poewe, Gregor Karl Wenning, Nadia Stefanova · 2015 · Neurotoxicity Research
  17. Extracellular Alpha-Synuclein: Mechanisms for Glial Cell Internalization and Activation
    Chavarría, Cecilia, Ivagnes, Rodrigo, Souza, José M. · 2022 · Biomolecules
  18. Vitamin D and Parkinson's disease
    Khanh vinh quốc Lương, Lan Nguyễn · 2012 · Journal of Neuroscience Research
  19. Manganese and related neurotoxic pathways: A potential therapeutic target in neurodegenerative diseases
    Shivani Chib, Shamsher Singh · 2022 · Neurotoxicology and Teratology
  20. Alpha-Synuclein and Microglia in Parkinson’s Disease: From Pathogenesis to Therapeutic Prospects
    Hyemi Eo, Sehwan Kim, Un Ju Jung, Sang Ryong Kim · 2024 · Journal of Clinical Medicine
  21. Altered Expression Patterns of Inflammation-Associated and Trophic Molecules in Substantia Nigra and Striatum Brain Samples from Parkinson's Disease, Incidental Lewy Body Disease and Normal Control Cases
    Douglas G. Walker, Lih‐Fen Lue, Geidy E. Serrano, Charles H. Adler, John N. Caviness, Lucia I. Sue, Thomas G. Beach · 2016 · Frontiers in Neuroscience
  22. Screening of Toll-Like Receptors Expression in Multiple System Atrophy Brains
    Brudek, Tomasz, Winge, Kristian, Agander, Tina Klitmøller, Pakkenberg, Bente · 2013 · Neurochemical Research
  23. PKC Delta Activation Promotes Endoplasmic Reticulum Stress (ERS) and NLR Family Pyrin Domain-Containing 3 (NLRP3) Inflammasome Activation Subsequent to Asynuclein-Induced Microglial Activation: Involvement of Thioredoxin-Interacting Protein (TXNIP)/Thioredoxin (Trx) Redoxisome Pathway
    Manikandan Samidurai, Bharathi N. Palanisamy, Alejandra Bargues-Carot, Monica Hepker, Naveen Chandra Kondru, Sireesha Manne, Gary D. Zenitsky, Huajun Jin, Vellareddy Anantharam, Anumantha G. Kanthasamy et al. · 2021 · Frontiers in Aging Neuroscience
  24. Possible Link between SARS-CoV-2 Infection and Parkinson’s Disease: The Role of Toll-Like Receptor 4
    Carmela Conte · 2021 · International Journal of Molecular Sciences
  25. Role of pattern recognition receptors and the microbiota in neurological disorders
    Ciara E. Keogh, Kavi M. Rude, Mélanie G. Gareau · 2021 · The Journal of Physiology
  26. The role of innate immunity and inflammation in Parkinson´s disease
    Maria Öberg, Ivo Fabrik, Daniela Fabriková, Nina Zehetner, Anetta Härtlová · 2021 · Scandinavian Journal of Immunology
  27. The role of the MYD88-dependent pathway in MPTP-induced brain dopaminergic degeneration
    Janelle Drouin‐Ouellet, Claire Gibrat, M. Bousquet, Frédéric Calon, Jasna Križ, Francesca Cicchetti · 2011 · Journal of Neuroinflammation
  28. Towards translational therapies for multiple system atrophy
    Daniela Kuzdas-Wood, Nadia Stefanova, K. A. Jellinger, Klaus Seppi, Michael G. Schlossmacher, Werner H Poewe, Gregor Karl Wenning · 2014 · Progress in Neurobiology
  29. RETRACTED ARTICLE: Effects of innate immune receptor stimulation on extracellular α-synuclein uptake and degradation by brain resident cells
    Changyoun Kim, Somin Kwon, Michiyo Iba, Brian J. Spencer, Edward M. Rockenstein, Michael Mante, Anthony Adame, Soo Jean Shin, Jerel Adam Fields, Robert A. Rissman et al. · 2021 · Experimental & Molecular Medicine · Retracted
  30. Sex differences in monocytes and TLR4 associated immune responses; implications for systemic lupus erythematosus (SLE)
    Wei Jiang, Gary S. Gilkeson · 2014 · Journal of Immunotherapy Applications
  31. Size-Selective Phagocytic Clearance of Fibrillar α-Synuclein through Conformational Activation of Complement Receptor 4
    Kristian Juul‐Madsen, Per Qvist, Kirstine L. Bendtsen, Annette E. Langkilde, Bente Vestergaard, Kenneth Alan Howard, Martxel Dehesa-Etxebeste, Søren R. Paludan, Gregers Rom Andersen, Poul Henning Jensen et al. · 2020 · The Journal of Immunology
  32. Repurposing Immunomodulatory Imide Drugs (IMiDs) in Neuropsychiatric and Neurodegenerative Disorders
    Yoo Jin Jung, David Tweedie, Michael T. Scerba, Dong Seok Kim, Maria Francesca Palmas, Augusta Pisanu, Anna Rosa Carta, Nigel H. Greig · 2021 · Frontiers in Neuroscience
  33. The involvement of α-synucleinopathy in the disruption of microglial homeostasis contributes to the pathogenesis of Parkinson’s disease
    Yongzhen Miao, Hongrui Meng · 2024 · Cell Communication and Signaling
  34. Endosomal-Lysosomal Processing of Neurodegeneration-Associated Proteins in Astrocytes
    Ching‐On Wong · 2020 · International Journal of Molecular Sciences
  35. Levodopa partially rescues microglial numerical, morphological, and phagolysosomal alterations in a monkey model of Parkinson’s disease
    Cynthia Lecours, Marie‐Kim St‐Pierre, Katherine Picard, Maude Bordeleau, Mélanie Bourque, Ifeoluwa Oluleke Awogbindin, Amin Benadjal, Fernando Gonzàlez Ibáñez, Dave Gagnon, Léo Cantin et al. · 2020 · Brain Behavior and Immunity
  36. Blood-brain Barrier and Neurovascular Unit Dysfunction in Parkinson's Disease: From Clinical Insights to Pathogenic Mechanisms and Novel Therapeutic Approaches
    Sarah Lei Qi Khor, Khuen Yen Ng, Rhun Yian Koh, Soi Moi Chye · 2023 · CNS & Neurological Disorders - Drug Targets
  37. Parkinson Disease: Translating Insights from Molecular Mechanisms to Neuroprotection
    Sheila K. Pirooznia, Liana S. Rosenthal, Valina Lynn Dawson, Ted M. Dawson · 2021 · Pharmacological Reviews
  38. The Role of Microglia and Astrocytes in the Pathomechanism of Neuroinflammation in Parkinson’s Disease—Focus on Alpha-Synuclein
    Oliwia Harackiewicz, Beata Grembecka · 2024 · Journal of Integrative Neuroscience
  39. The Potential Role of Toll-Like Receptor 4 in Mediating Dopaminergic Cell Loss and Alpha-Synuclein Expression in the Acute MPTP Mouse Model of Parkinson’s Disease
    Giuseppina Mariucci, Rita Pagiotti, Francesco Galli, Luigina R. Romani, Carmela Conte · 2018 · Journal of Molecular Neuroscience
  40. Region-Specific Effects of Immunotherapy With Antibodies Targeting α-synuclein in a Transgenic Model of Synucleinopathy
    Martin Kallab, Marcos Herrera-Vaquero, Malin Johannesson, Fredrik Eriksson, Jessica Sigvardson, Werner H Poewe, Gregor Karl Wenning, Eva K. L. Nordström, Nadia Stefanova · 2018 · Frontiers in Neuroscience
  41. Extracellular tau stimulates phagocytosis of living neurons by activated microglia via Toll-like 4 receptor–NLRP3 inflammasome–caspase-1 signalling axis
    Katryna Pampuščenko, Ramunė Morkūnienė, Lukas Krasauskas, Vytautas Smirnovas, Guy Charles Brown, Vilmantė Borutaitė · 2023 · Scientific Reports
  42. Modeling Parkinson’s Disease Neuropathology and Symptoms by Intranigral Inoculation of Preformed Human α-Synuclein Oligomers
    Laura Boi, Augusta Pisanu, Maria Francesca Palmas, Giuliana Fusco, Ezio Carboni, Maria Antonietta Casu, Valentina Satta, María Scherma, Elżbieta Janda, Ignazia Mocci et al. · 2020 · International Journal of Molecular Sciences
  43. Evidence of Inflammation in Parkinson’s Disease and Its Contribution to Synucleinopathy
    Lai, Thuy Thi, Kim, Yun Joong, Ma, Hyeo-il, Kim, Young Eun · 2022 · Journal of Movement Disorders
  44. The role of glia in Parkinson's disease: Emerging concepts and therapeutic applications
    Katarzyna Z. Kuter, Maria Angela Cenci, Anna Rosa Carta · 2020 · Progress in brain research
  45. Toll-like receptor 4 deficiency facilitates α-synuclein propagation and neurodegeneration in a mouse model of prodromal Parkinson's disease
    Serena Venezia, Walter Anton Kaufmann, Gregor Karl Wenning, Nadia Stefanova · 2021 · Parkinsonism & Related Disorders
  46. Toll-like Receptor 4 Is Upregulated in Parkinson’s Disease Patients and Co-Localizes with pSer129αSyn: A Possible Link with the Pathology
    Carmela Conte, Angela M. T. Ingrassia, John J. P. Brevé, John G. J. M. Bol, Evelien Huisman, Anne‐Marie van Dam, Tommaso Beccari, Wilma D. J. van de Berg · 2023 · Cells
  47. The Role of Glial Mitochondria in α-Synuclein Toxicity
    Yu‐Mi Jeon, Younghwi Kwon, Myungjin Jo, Shinrye Lee, Seyeon Kim, Hyung‐Jun Kim · 2020 · Frontiers in Cell and Developmental Biology
  48. Proteostasis Perturbations and Their Roles in Causing Sterile Inflammation and Autoinflammatory Diseases
    Jonas Johannes Papendorf, Elke Krüger, Frédéric Ebstein · 2022 · Cells
  49. Exosomes in Alpha-Synucleinopathies: Propagators of Pathology or Potential Candidates for Nanotherapeutics?
    Panagiota Mavroeidi, Maria Vetsi, Dimitra Dionysopoulou, Maria Xilouri · 2022 · Biomolecules
  50. Understanding the Role of Innate Immunity in the Response to Intracortical Microelectrodes
    John K. Hermann, Jeffrey R. Capadona · 2018 · Critical Reviews in Biomedical Engineering
  51. A multi-platform analysis of human gingival crevicular fluid reveals ferroptosis as a relevant regulated cell death mechanism during the clinical progression of periodontitis
    Alfredo Torres, María Angélica Michea, Ákos Végvári, Marion Arce, Valentina Pérez, Marcela Alcota, Alicia Morales, Rolando Vernal, Mauricio Budini, Roman A. Zubarev et al. · 2024 · International Journal of Oral Science
  52. Extracellular vesicles can act as a potent immunomodulators of human microglial cells
    Ugnė Jonavičė, Virginijus Tunaitis, Karolina Kriaučiūnaitė, Akvilė Jarmalavičiūtė, Augustas Pivoriūnas · 2019 · Journal of Tissue Engineering and Regenerative Medicine
  53. Patient-Derived Induced Pluripotent Stem Cell-Based Models in Parkinson’s Disease for Drug Identification
    Georgia Kouroupi, Nasia Antoniou, Kanella Prodromidou, Era Taoufik, Rebecca Matsas · 2020 · International Journal of Molecular Sciences
  54. Changes in the miRNA-mRNA Regulatory Network Precede Motor Symptoms in a Mouse Model of Multiple System Atrophy: Clinical Implications
    Simon Schafferer, Rimpi Khurana, Violetta Refolo, Serena Venezia, Edith Sturm, Paolo Piatti, Clara Hechenberger, Hubert Hackl, Roman Kessler, Michaela Willi et al. · 2016 · PLoS ONE
  55. Non-cell-autonomous actions of α-synuclein: Implications in glial synucleinopathies
    Somin Lim, Han‐Joon Kim, Dong‐Kyu Kim, Seung‐Jae Lee · 2018 · Progress in Neurobiology
  56. ATH434 Reduces α‐Synuclein‐Related Neurodegeneration in a Murine Model of Multiple System Atrophy
    Antonio Heras‐Garvin, Violetta Refolo, Claudio Schmidt, Katja Malfertheiner, Gregor Karl Wenning, MARGARET J. BRADBURY, David A. Stamler, Nadia Stefanova · 2021 · Movement Disorders
  57. When Human Immunodeficiency Virus Meets Chemokines and Microglia: Neuroprotection or Neurodegeneration?
    Italo Mocchetti, Lee Ann Campbell, Gaylia Jean Harry, Valeriya Avdoshina · 2012 · Journal of Neuroimmune Pharmacology
  58. Polymer brain-nanotherapeutics for multipronged inhibition of microglial α-synuclein aggregation, activation, and neurotoxicity
    Neal K. Bennett, Rebecca Chmielowski, Dalia S. Abdelhamid, Jonathan J. Faig, Nicola Louise Francis, Jean Baum, Zhiping P. Pang, Kathryn E. Uhrich, Prabhas V. Moghe · 2016 · Biomaterials
  59. Relationship among α‑synuclein, aging and inflammation in Parkinson's disease (Review)
    Nianping Zhang, Zhaoli Yan, Xin Hua, Shuai Shao, Song Xue, Raymond Cespuglio, Shijun Wang · 2023 · Experimental and Therapeutic Medicine
  60. Prelysosomal Compartments in the Unconventional Secretion of Amyloidogenic Seeds
    Helena Borland Madsen, Frederik Vilhardt · 2017 · International Journal of Molecular Sciences
  61. In Search of Effective Treatments Targeting α-Synuclein Toxicity in Synucleinopathies: Pros and Cons
    Maria Fouka, Panagiota Mavroeidi, Grigoria Tsaka, Maria Xilouri · 2020 · Frontiers in Cell and Developmental Biology
  62. MeCP2 deficiency enhances glutamate release through NF-κB signaling in myeloid derived cells
    Cliona M. O’Driscoll, Walter E. Kaufmann, Joseph Paul Bressler · 2013 · Journal of Neuroimmunology
  63. An update on the cerebellar subtype of multiple system atrophy
    Ludovico Ciolli, Florian Krismer, Ferdinando Nicoletti, Gregor Karl Wenning · 2014 · Cerebellum & Ataxias
  64. Let’s make microglia great again in neurodegenerative disorders
    Marie‐Victoire Guillot‐Sestier, Terrence Town · 2017 · Journal of Neural Transmission
  65. Advances in modelling alpha-synuclein-induced Parkinson’s diseases in rodents: Virus-based models versus inoculation of exogenous preformed toxic species
    Anna Rosa Carta, Laura Boi, Augusta Pisanu, Maria Francesca Palmas, Ezio Carboni, Alfonso De Simone · 2020 · Journal of Neuroscience Methods
  66. Disease-Modifying Therapies for Multiple System Atrophy: Where Are We in 2022?
    Victoria Sidoroff, Pam Bower, Nadia Stefanova, Alessandra Fanciulli, Iva Stankovic, Werner H Poewe, Klaus Seppi, Gregor Karl Wenning, Florian Krismer · 2022 · Journal of Parkinson s Disease
  67. The Role of Toll-Like Receptor 2 and 4 Innate Immunity Pathways in Intracortical Microelectrode-Induced Neuroinflammation
    John K. Hermann, Shushen Lin, Arielle Soffer, Chun Wong, A. Ali, Jeremy B. Chang, Smrithi Sunil, Shruti Sudhakar, William H. Tomaszewski, Grace Protasiewicz et al. · 2018 · Frontiers in Bioengineering and Biotechnology
  68. Aspects of innate immunity and Parkinson's disease
    Huang, Yue, Halliday, Glenda M. · 2012 · Frontiers in Pharmacology
  69. Neuroprotective approaches to halt Parkinson's disease progression
    Piyong Sola, Praveen Thaggikuppe Krishnamurthy, Mamta Kumari, Gowramma Byran, Hosahalli Veerabhadrappa Gangadharappa, Kusuma Kumari Garikapati · 2022 · Neurochemistry International
  70. Neuroinflammatory gene expression profiles of reactive glia in the substantia nigra suggest a multidimensional immune response to alpha synuclein inclusions
    Anna C. Stoll, Christopher J. Kemp, Joseph R. Patterson, Jacob W. Howe, Kathy Steece‐Collier, Kelvin C. Luk, Caryl E. Sortwell, Matthew J. Benskey · 2024 · Neurobiology of Disease
  71. Remodeling microglia to a protective phenotype in Parkinson’s disease?
    Ifeoluwa Oluleke Awogbindin, Ismail Ogunbayode Ishola, Marie‐Kim St‐Pierre, Micaël Carrier, Julie C. Savage, Thérèse Di Paolo, Marie‐Ève Tremblay · 2020 · Neuroscience Letters
  72. Understanding the influence of TLR-mediated immune system on necroptosis-induced neurodegeneration in Parkinson’s disease
    Vaishnavi Suresh Jadhav, Dharmendra Kumar Khatri · 2025 · Ageing Research Reviews
  73. Host oligodendrogliopathy and α-synuclein strains dictate disease severity in multiple system atrophy
    Teresa Torre-Muruzabal, Anke Van der Perren, Audrey Coens, Géraldine Gelders, Anna Barber Janer, Sara Camacho-Garcia, Therése Klingstedt, K. Peter R. Nilsson, Nadia Stefanova, Ronald Melki et al. · 2022 · Brain
  74. How Toll-like receptors influence Parkinson’s disease in the microbiome–gut–brain axis
    Ziyi Zhang, Zhihui Liu, Ao Lv, Chenhui Fan · 2023 · Frontiers in Immunology
  75. Emerging roles of protein kinases in microglia-mediated neuroinflammation
    Sun Hwa Lee, Kyoungho Suk · 2017 · Biochemical Pharmacology
  76. Epothilone D inhibits microglia-mediated spread of alpha-synuclein aggregates
    Valdinocci, Dario, Grant, Gary D., Dickson, Tracey C., Pountney, Dean L. · 2018 · Molecular and Cellular Neuroscience
  77. Patient-Derived Induced Pluripotent Stem Cells and Organoids for Modeling Alpha Synuclein Propagation in Parkinson's Disease
    Yong Hui Koh, Li Yi Tan, Shi‐Yan Ng · 2018 · Frontiers in Cellular Neuroscience
  78. Multiple system atrophy - a clinicopathological update
    K. A. Jellinger · 2020 · Free Neuropathology
  79. Mechanistic Insight from Preclinical Models of Parkinson’s Disease Could Help Redirect Clinical Trial Efforts in GDNF Therapy
    Karen M. Delgado-Minjares, Daniel Martínez‐Fong, Irma Alicia Martínez-Dávila, Cecilia Bañuelos, María Eugenia Gutiérrez-Castillo, Víctor Manuel Blanco-Álvarez, María del Carmen Cárdenas‐Aguayo, José Luna‐Muñoz, Mar Pacheco‐Herrero, Luis Oskar Soto-Rojas · 2021 · International Journal of Molecular Sciences
  80. The immunomodulatory roles of the gut microbiome in autoimmune diseases of the central nervous system: Multiple sclerosis as a model
    Kristina R Hoffman, Zackariah Brownell, William J. Doyle, Javier Ochoa‐Repáraz · 2022 · Journal of Autoimmunity
  81. Toll Like Receptor 4 Affects the Cerebral Biochemical Changes Induced by MPTP Treatment
    Carmela Conte, Luca Roscini, Roccaldo Sardella, Giuseppina Mariucci, Stefania Scorzoni, Tommaso Beccari, Laura Corte · 2017 · Neurochemical Research
  82. “Multiple system atrophy: experimental models and reality”.
    C. Overk, E. Rockenstein, Elvira Valera, N. Stefanova, G. Wenning, E. Masliah · 2017 · Acta Neuropathologica
  83. MSA: From basic mechanisms to experimental therapeutics
    Antonio Heras‐Garvin, Nadia Stefanova · 2020 · Parkinsonism & Related Disorders
  84. Eicosanoid receptor subtype‐mediated opposing regulation of TLR‐stimulated expression of astrocyte glial‐derived neurotrophic factor
    Xianwu Li, Eiron Cudaback, RICHARD M. BREYER, Kathleen S. Montine, Christopher Dirk Keene, Thomas Jude Montine · 2012 · The FASEB Journal
  85. Models of Multiple System Atrophy
    Lisa Fellner, Gregor Karl Wenning, Nadia Stefanova · 2013 · Current topics in behavioral neurosciences
  86. Dual Roles of Microglia in the Basal Ganglia in Parkinson’s Disease
    Mohammed Emamussalehin Choudhury, Yuka Kigami, Junya Tanaka · 2021 · International Journal of Molecular Sciences
  87. Potential for Therapeutic-Loaded Exosomes to Ameliorate the Pathogenic Effects of α-Synuclein in Parkinson’s Disease
    David J. Rademacher · 2023 · Biomedicines
  88. Current experimental disease-modifying therapeutics for multiple system atrophy
    Miguel Lemos, Gregor Karl Wenning, Nadia Stefanova · 2021 · Journal of Neural Transmission
  89. Spreading of alpha-synuclein between different cell types
    Wolfgang Philipp Ruf, João L. Meirelles, Karin M. Danzer · 2022 · Behavioural Brain Research
  90. Emerging role of microglia in inter-cellular transmission of α-synuclein in Parkinson’s disease
    Xiangbo Zhang, Haiyang Yu, Juan Feng · 2024 · Frontiers in Aging Neuroscience
  91. Modulation of Innate Immunity by Amyloidogenic Peptides
    Clara Y. Westwell-Roper, C. Bruce Verchere · 2019 · Trends in Immunology
  92. Toll-Like Receptor 4 Signaling in Focal Cerebral Ischemia: a Focus on the Neurovascular Unit
    Bolanle M. Famakin, Raghu Vemuganti · 2020 · Molecular Neurobiology
  93. In vivo quantification of glial activation in minipigs overexpressing human α‐synuclein
    Thea Pinholt Lillethorup, Andreas Nørgaard Glud, Natalie Landeck, Aage Kristian Olsen Alstrup, Steen Jakobsen, Kim Vang, Doris J. Doudet, David James Brooks, Deniz Kirik, Rainer Hinz et al. · 2018 · Synapse
  94. Recent Developments in Targeting Neuroinflammation in Disease
    Allen T. Hopper, Brian M. Campbell, Henry W. Kao, Sean A. Pintchovski, Roland G. W. Staal · 2012 · Annual reports in medicinal chemistry
  95. Knockdown of TLR4 represses the paraquat-induced neuroinflammation and microglial M1 polarization
    Huang, Min, Li, Yingying, Tian, Tian, Wang, Kai, Wang, Yifan, Yan, Weiguang, Yang, Huifang · 2020 · Neurotoxicity Research
  96. A functional role for alpha-synuclein in neuroimmune responses
    Dustin L. Heiden, Brendan Monogue, Muhammad Ali, John David Beckham · 2023 · Journal of Neuroimmunology
  97. Olfactory Dysfunction and Its Association With Neuropathologic Proteins in Cerebrospinal Fluid From Patients With Parkinson Disease
    Peng Fei Guo, Ruidan Wang, Tenghong Lian, Du-yu Ding, Yanan Zhang, Weijiao Zhang, Dan-ning Li, Lixia Li, Jinghui Li, Huiying Guan et al. · 2020 · Frontiers in Aging Neuroscience
  98. The Multifaceted Role of LRRK2 in Parkinson’s Disease
    Dong Hwan Ho, Sun Jung Han, Ilhong Son · 2025 · Brain Sciences
  99. Mesenchymal stem cells modulate misfolded α-synuclein in parkinsonian disorders: A multitarget disease-modifying strategy
    Jin Young Shin, Phil Hyu Lee · 2020 · Stem Cell Research
  100. The implication of neuronimmunoendocrine (NIE) modulatory network in the pathophysiologic process of Parkinson’s disease
    Yan Shen, Xingfang Guo, Chao Han, Fang Jung Wan, Kai Ma, Shiyi Guo, Luxi Wang, Yun Fei Xia, Ling Liu, Zhicheng Lin et al. · 2017 · Cellular and Molecular Life Sciences